BRUKER CORPORATION Restricted Cash and Cash Equivalents, Noncurrent
BRUKER CORPORATION (BRKR) had Restricted Cash and Cash Equivalents, Noncurrent of $4.00 million as of 2013-12-31, per its 10-K filed 2014-02-27.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2014-02-27
- 2013-12-31: Restricted Cash and Cash Equivalents, Noncurrent $4.00M.
- 2012-12-31: Restricted Cash and Cash Equivalents, Noncurrent $3.90M.
- 2011-12-31: Restricted Cash and Cash Equivalents, Noncurrent $3.90M.
- 2010-12-31: Restricted Cash and Cash Equivalents, Noncurrent $3.50M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2013-12-31 | $4.00M 10-K · filed 2014-02-27 |
| 2012-12-31 | $3.90M 10-K · filed 2014-02-27 |
| 2011-12-31 | $3.90M 10-K · filed 2013-02-28 |
| 2010-12-31 | $3.50M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |